Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
adverse drug reactions
Research
Lipid may hold the key to new liver drugs
New research may finally offer a way to confer the benefits of SCD1 inhibitors without the associated serious side effects.
James Waldron
Jun 7, 2022 6:00am
Aligos calls it quits on 2nd med after 'unexpected' reactions
Mar 22, 2022 10:40am
Redx cleared to start Wnt cancer trial again after safety scare
Jan 21, 2019 9:05am
Redx pauses WNT cancer trial following adverse events
Mar 29, 2018 3:35am
Seattle Genetics stops all trials of '33A blood cancer drug
Jun 19, 2017 9:37am
Patient death raises doubts about safety of Roche’s emicizumab
Feb 24, 2017 4:37am
